Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05041257
Title Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ImmunoGen, Inc.

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer


Mirvetuximab Soravtansine

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

No variant requirements are available.